Lovastatin
-
Identifiers
CAS number
75330-75-5Molecular formula
C24H36O5SMILES
CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C
Safety labels
Irritant
Health -
Odor profile
Fragrance Woody 40.86% Floral 37.49% Green 34.72% Jasmin 32.85% Herbal 32.15% Lactonic 30.1% Fresh 27.8% Spicy 26.9% Sweet 25.95% Mint 24.33% Flavor Bitter 61.54% Cedarleaf 22.6% Minty 22.42% Herbal 21.52% Lovage 20.74% Sweet-like 20.01% Leaves 19.99% Ripe apricot 19.81% Parsley 19.65% Basil 19.65% Odor impact est.
Low -
Properties
XLogP3-AA
4.3pKa est.
6.52 (neutral)Molecular weight
404.5 g/molVapor pressure est.
- hPa @ 20°C
- hPa @ 25°C
Evaporation rate
Ultra slowMelting point expt.
- 174.5 °C
- 179 °C
- MP: 174.5 °C (under nitrogen)
Boiling point
- 559.2 ºC at 760 mmHg
Flash point
- 189.25 ˚C est.
Solubility expt.
- 0.0004 mg/mL
- In water, 0.4X10-3 mg/mL at 25 °C
- Insoluble in water
- Solubility at 25 °C (mg/mL): acetone 47, acetonitrile 28, n-butanol 7, iso-butanol 14, chloroform 350, N,N-dimethylformamide 90, ethanol 16, methanol 28, n-octanol 2, n-propanol 11, iso-propanol 20
- Practically insoluble in hexane
- Very soluble in chloroform; soluble in dimethyl formamide; slightly soluble in acetone, ethanol
- 2.43e-02 g/L
-
Synonyms
- lovastatin
- 75330-75-5
- mevinolin
- Mevacor
- Lovalip
- Altoprev
- Mevlor
- Sivlor
- Lovalord
- Nergadan
- Altocor
- Artein
- MK-803
- Monacolin K
- Cholestra
- Closterol
- Hipovastin
- Lestatin
- Lipofren
- Lovastatine
- Lovasterol
- Lovastin
- Tecnolip
- Teroltrat
- 6alpha-Methylcompactin
- Belvas
- Colevix
- Hipolip
- Lipdip
- Lipivas
- Lozutin
- Paschol
- Rodatin
- Rovacor
- Taucor
- Lovastatina
- 6-alpha-Methylcompactin
- Mevinacor
- Lovastatine [French]
- Lovastatinum [Latin]
- Lovastatina [Spanish]
- Lovastatinum
- MSD 803
- HSDB 6534
- UNII-9LHU78OQFD
- 9LHU78OQFD
- (+)-mevinolin
- NSC-758662
- Lovastatin [USAN]
- BRN 3631989
- CCRIS 8092
- MLS000069585
- butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-
- DTXSID5020784
- L-154803
- CHEBI:40303
- Lovastatin (Standard)
- C10AA02
- ML-530B
- 6.alpha.-Methylcompactin
- MFCD00072164
- [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
- MK 803
- 2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone
- SMR000058779
- DTXCID50784
- (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate
- (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
- (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
- EC 616-212-7
- ADVICOR COMPONENT LOVASTATIN
- Lovastatin [USAN:USP:INN:BAN]
- 6-Methylcompactin
- NSC633781
- Lovastatin (Mevacor)
- Lovastatinum (Latin)
- NSC 758662
- NCGC00023509-03
- 6 Methylcompactin
- LOVASTATIN (MART.)
- LOVASTATIN [MART.]
- LOVASTATIN (USP-RS)
- LOVASTATIN [USP-RS]
- LOVASTATIN (EP MONOGRAPH)
- LOVASTATIN [EP MONOGRAPH]
- Liposcler
- LOVASTATIN (USP MONOGRAPH)
- LOVASTATIN [USP MONOGRAPH]
- 6 alpha-Methylcompactin
- Rextat
- Lovastatin (USAN:USP:INN:BAN)
- Monakolin K
- (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-8-(2-((4R,6R)-4-hydroxy-2-oxo-2H-pyran-6-yl)ethyl)-3,7-dimethylnaphtyl(S)-2-methylbutyrat
- (S)-(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methylbutanoate
- Mevacor (TN)
- SIMVASTATIN IMPURITY E (EP IMPURITY)
- SIMVASTATIN IMPURITY E [EP IMPURITY]
- CHEMBL503
- Lovastatin & Primycin
- Lovastatin (USP/INN)
- SR-05000001880
- (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-2-Methylbutanoic acid 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
- (S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
- 1,2,6,7,8,8a-Hexahydro-beta,delta-dihydroxy-2,6-dimethyl-8-(2-methyl-1-oxobutyoxy)-1-naphthaleneheptanoic acid delta-lactone
- Mevinolin from Aspergillus sp.
- 1cqp
- (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
- (2S)-2-METHYLBUTANOIC ACID (1S,3R,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-((2R,4R)-TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL ESTER
- (2S)-2-Methylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
- [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
- 1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl 2-methylbutanoate
- Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-
- Prestwick_819
- CAS-75330-75-5
- 74133-25-8
- Mevinolin (lovastatin)
- LOVASTATIN [MI]
- LOVASTATIN [INN]
- Opera_ID_1578
- Prestwick0_000516
- Prestwick1_000516
- Prestwick2_000516
- Prestwick3_000516
- Spectrum3_001873
- Spectrum5_001294
- Lovastatin (MK-803)
- LOVASTATIN [HSDB]
- LOVASTATIN [VANDF]
-
Applications
Lovastatin, CAS 75330-75-5, is primarily used as an active pharmaceutical ingredient (API) in statin-class medicines, where it inhibits HMG-CoA reductase as part of lipid-management pharmacology. It is produced by microbial fermentation, reflecting its biotechnological origin and role in industrial pharmaceutical manufacturing. In analytical and quality-control workflows, it is commonly employed as a reference standard for method development and assay validation (e.g., LC methods for statins). It is also used in research and development for statin-related enzyme inhibition studies and formulation development, with potential consideration as a benchmark compound in pharmaceutical analytics and process development.
gpt-5-nano
-
Solubility @25˚C
Solvent Solubility (g/L) ethanol 60.9 methanol 40.43 isopropanol 51.12 water 0.04 ethyl acetate 31.17 n-propanol 64.27 acetone 78.25 n-butanol 59.74 acetonitrile 22.79 DMF 87.31 toluene 45.88 isobutanol 48.63 1,4-dioxane 112.14 methyl acetate 27.85 THF 218.5 2-butanone 58.43 n-pentanol 52.79 sec-butanol 48.91 n-hexane 3.2 ethylene glycol 4.08 NMP 123.48 cyclohexane 5.86 DMSO 98.2 n-butyl acetate 29.62 n-octanol 24.81 chloroform 172.53 n-propyl acetate 24.86 acetic acid 79.36 dichloromethane 125.78 cyclohexanone 108.73 propylene glycol 12.77 isopropyl acetate 24.75 DMAc 151.84 2-ethoxyethanol 73.94 isopentanol 53.16 n-heptane 1.52 ethyl formate 21.44 1,2-dichloroethane 81.91 n-hexanol 49.25 2-methoxyethanol 80.91 isobutyl acetate 19.65 tetrachloromethane 18.16 n-pentyl acetate 35.69 transcutol 335.01 n-heptanol 29.0 ethylbenzene 20.06 MIBK 40.75 2-propoxyethanol 106.15 tert-butanol 40.87 MTBE 32.26 2-butoxyethanol 69.81 propionic acid 35.14 o-xylene 26.92 formic acid 20.23 diethyl ether 47.1 m-xylene 27.5 p-xylene 22.11 chlorobenzene 46.82 dimethyl carbonate 21.73 n-octane 0.89 formamide 27.12 cyclopentanone 117.93 2-pentanone 54.14 anisole 35.08 cyclopentyl methyl ether 69.75 gamma-butyrolactone 96.72 1-methoxy-2-propanol 85.42 pyridine 79.03 3-pentanone 44.26 furfural 81.2 n-dodecane 0.86 diethylene glycol 63.22 diisopropyl ether 11.8 tert-amyl alcohol 38.88 acetylacetone 56.9 n-hexadecane 1.02 acetophenone 38.98 methyl propionate 34.28 isopentyl acetate 35.59 trichloroethylene 161.11 n-nonanol 26.41 cyclohexanol 56.8 benzyl alcohol 43.31 2-ethylhexanol 24.76 isooctanol 23.81 dipropyl ether 21.92 1,2-dichlorobenzene 42.92 ethyl lactate 23.31 propylene carbonate 44.68 n-methylformamide 36.45 2-pentanol 38.91 n-pentane 3.51 1-propoxy-2-propanol 65.15 1-methoxy-2-propyl acetate 51.12 2-(2-methoxypropoxy) propanol 75.78 mesitylene 14.81 ε-caprolactone 86.43 p-cymene 12.32 epichlorohydrin 137.96 1,1,1-trichloroethane 60.9 2-aminoethanol 19.26 morpholine-4-carbaldehyde 120.23 sulfolane 126.58 2,2,4-trimethylpentane 2.66 2-methyltetrahydrofuran 101.33 n-hexyl acetate 51.47 isooctane 1.69 2-(2-butoxyethoxy)ethanol 113.95 sec-butyl acetate 19.15 tert-butyl acetate 31.83 decalin 3.86 glycerin 22.43 diglyme 161.53 acrylic acid 33.06 isopropyl myristate 19.65 n-butyric acid 52.63 acetyl acetate 26.44 di(2-ethylhexyl) phthalate 33.36 ethyl propionate 22.04 nitromethane 71.18 1,2-diethoxyethane 66.04 benzonitrile 35.14 trioctyl phosphate 20.69 1-bromopropane 47.77 gamma-valerolactone 151.74 n-decanol 17.92 triethyl phosphate 18.32 4-methyl-2-pentanol 25.04 propionitrile 25.6 vinylene carbonate 45.26 1,1,2-trichlorotrifluoroethane 98.6 DMS 37.31 cumene 13.97 2-octanol 16.89 2-hexanone 40.27 octyl acetate 28.98 limonene 17.61 1,2-dimethoxyethane 76.22 ethyl orthosilicate 18.65 tributyl phosphate 22.48 diacetone alcohol 54.26 N,N-dimethylaniline 29.12 acrylonitrile 27.97 aniline 52.42 1,3-propanediol 42.33 bromobenzene 45.78 dibromomethane 88.46 1,1,2,2-tetrachloroethane 130.8 2-methyl-cyclohexyl acetate 33.54 tetrabutyl urea 32.54 diisobutyl methanol 13.53 2-phenylethanol 47.87 styrene 21.59 dioctyl adipate 35.05 dimethyl sulfate 37.05 ethyl butyrate 22.65 methyl lactate 32.15 butyl lactate 37.86 diethyl carbonate 16.44 propanediol butyl ether 63.89 triethyl orthoformate 22.67 p-tert-butyltoluene 11.13 methyl 4-tert-butylbenzoate 55.25 morpholine 133.09 tert-butylamine 22.49 n-dodecanol 11.78 dimethoxymethane 83.91 ethylene carbonate 38.8 cyrene 67.81 2-ethoxyethyl acetate 62.16 2-ethylhexyl acetate 28.06 1,2,4-trichlorobenzene 54.67 4-methylpyridine 69.35 dibutyl ether 21.82 2,6-dimethyl-4-heptanol 13.53 DEF 52.4 dimethyl isosorbide 105.76 tetrachloroethylene 86.64 eugenol 53.39 triacetin 60.98 span 80 66.39 1,4-butanediol 21.55 1,1-dichloroethane 67.27 2-methyl-1-pentanol 48.09 methyl formate 25.61 2-methyl-1-butanol 55.14 n-decane 1.75 butyronitrile 29.67 3,7-dimethyl-1-octanol 24.57 1-chlorooctane 11.93 1-chlorotetradecane 4.13 n-nonane 1.4 undecane 1.17 tert-butylcyclohexane 2.83 cyclooctane 2.0 cyclopentanol 56.85 tetrahydropyran 103.88 tert-amyl methyl ether 30.82 2,5,8-trioxanonane 112.06 1-hexene 15.5 2-isopropoxyethanol 58.82 2,2,2-trifluoroethanol 26.56 methyl butyrate 26.6 Scent© AI
| Maximum acceptable concentrations in the finished product (%) | |||
|---|---|---|---|
|
Category 1
Products applied to the lips
|
No restriction |
Category 7A
Rinse-off products applied to the hair with some hand contact
|
No restriction |
|
Category 2
Products applied to the axillae
|
No restriction |
Category 7B
Leave-on products applied to the hair with some hand contact
|
No restriction |
|
Category 3
Products applied to the face/body using fingertips
|
No restriction |
Category 8
Products with significant anogenital exposure
|
No restriction |
|
Category 4
Products related to fine fragrance
|
No restriction |
Category 9
Products with body and hand exposure, primarily rinse off
|
No restriction |
|
Category 5A
Body lotion products applied to the body using the hands (palms), primarily leave on
|
No restriction |
Category 10A
Household care products with mostly hand contact
|
No restriction |
|
Category 5B
Face moisturizer products applied to the face using the hands (palms), primarily leave on
|
No restriction |
Category 10B
Household care products with mostly hand contact, including aerosol/spray products (with potential leave-on skin contact)
|
No restriction |
|
Category 5C
Hand cream products applied to the hands using the hands (palms), primarily leave on
|
No restriction |
Category 11A
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate without UV exposure
|
No restriction |
|
Category 5D
Baby Creams, baby Oils and baby talc
|
No restriction |
Category 11B
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate with potential UV exposure
|
No restriction |
|
Category 6
Products with oral and lip exposure
|
No restriction |
Category 12
Products not intended for direct skin contact, minimal or insignificant transfer to skin
|
No restriction |